The Discounted Cash Flow (DCF) valuation of Abbott Laboratories (ABT) is 148.62 USD. With the latest stock price at 127.04 USD, the upside of Abbott Laboratories based on DCF is 17.0%.
Based on the latest price of 127.04 USD and our DCF valuation, Abbott Laboratories (ABT) is a buy. buying Abbott stocks now will result in a potential gain of 17.0%.
| Range | Selected | |
| WACC / Discount Rate | 6.7% - 8.6% | 7.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 99.28 - 306.52 | 148.62 |
| Upside | -21.9% - 141.3% | 17.0% |